04/18/2024
4:23 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/18/2024
4:25 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:40 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:37 PM | Intra-Cellular Therapies (Filer)
| Form 424B5 | |
04/16/2024
6:10 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/01/2024
4:15 PM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
7:44 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:31 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:32 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:33 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:33 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:52 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:38 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:45 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
3:30 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
4:58 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:58 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:58 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
4:59 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
3:44 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:36 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:27 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:04 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:05 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:41 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:57 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:59 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
7:00 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
7:00 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:22 PM | Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:46 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:46 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad) AI was by far the biggest tech investing trend right now.
But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple.
Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now…
And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… |
02/26/2024
3:33 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
3:22 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/22/2024
6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
6:42 AM | Intra-Cellular Therapies (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/09/2024
11:40 AM | Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
| Form SC 13G/A | |
02/05/2024
5:02 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:07 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:13 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:47 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:39 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
3:41 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/18/2024
6:47 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
4:08 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
5:02 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:45 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
6:54 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:43 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:46 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
3:38 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
10:15 AM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023
3:52 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023
4:31 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
3:15 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
12:06 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
7:01 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
7:01 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
4:29 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
4:30 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
7:40 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:13 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
3:13 PM | Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2023
3:18 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2023
3:40 PM | Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
5:05 PM | Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
5:09 PM | Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
6:39 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:44 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/20/2023
4:47 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:13 PM | Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023
5:07 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023
5:07 PM | Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4/A | |
07/07/2023
5:08 PM | Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
| Form 4/A | |
07/05/2023
3:30 PM | Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
3:30 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:11 PM | Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:11 PM | Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:12 PM | Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
4:12 PM | Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Incredible Opportunity to Retire FAST! (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
06/16/2023
4:05 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
3:28 PM | Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
6:45 AM | Intra-Cellular Therapies (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:37 AM | Intra-Cellular Therapies (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
